Search clinical trials for: Ticagrelor monotherapy

Total 852 results

Centre hospitalier de l'Université de Montréal...

Terminated

Phase I-II Study on Treatment of Advanced Oropharynx Cancer in Elderly Population by Intensity Modulated Radiotherapy With Treatment Volume Reduction and Combination Chemotherapy

Head and Neck Cancer

Canada
Xencor, Inc.

Recruiting

XmAb®20717 (Vudalimab) Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer

Metastatic Castration-Resistant Prostate Cancer

United States
Assistance Publique - Hôpitaux de Paris
Swedish Orphan Biovitrum

Recruiting

A Trial Comparing the Efficacy and Safety of Anakinra Versus Intravenous Immunoglobulin (IVIG) Retreatment, in Patients With Kawasaki Disease Who Failed to Respond to Initial Standard IVIG Treatment (ANACOMP)

Kawasaki Disease

France
National Institute of Cardiovascular Diseases,...

Completed

Safety and Tolerability of Sacubitril/Valsartan in Heart Failure Patient With Reduced Ejection Fraction

Heart Failure, Systolic

Pakistan
The Royal Wolverhampton Hospitals NHS Trust

Completed

The Effect of IV Cangrelor and Oral Ticagrelor Study

ST-segment Elevation Myocardial Infarction (STEMI) | Acute Coronary Syndrome (ACS) | Unstable Angina (UA) | High On-treatment Platelet Reactivity (HTPR) | Microvascular Obstruction (MVO) | Thrombolysis in Myocardial Infarction (TIMI)

United Kingdom
Nanjing First Hospital, Nanjing Medical University

Completed

Optical Coherence Tomography to Evaluate Ticagrelor and Clopidogrel

Thrombosis

China
Ottawa Heart Institute Research Corporation

Completed

Ticagrelor vs Clopidogrel Effect on MFR in CAD Population (PATH)

Coronary Artery Disease

Canada
Northside Hospital, Inc.

Not yet recruiting

Adding Venetoclax to the High-dose Chemotherapy Regimen Prior to Mismatche Allogeneic Stem Cell Transplant

Acute Myeloid Leukemia | Myelodysplastic Syndromes

United States
Yonsei University

Recruiting

Appropriate Duration of Anti-Platelet and Thrombotic Strategy After 12 Months in Patients With Atrial Fibrillation Treated With Drug Eluting Stents

Atrial Fibrillation

Korea, Republic of
ViiV Healthcare
GlaxoSmithKline

Completed

PRJ2203: Dolutegravir Post Authorization Safety Study (PASS)

Infection, Human Immunodeficiency Virus I
University of Colorado, Denver

Completed

Estrogen Sensitivity and Ovulatory Dysfunction in Obesity

Obesity | Infertility

United States
Vejle Hospital

Completed

Panitumumab and Pegylated Liposomal Doxorubicin for Platinum-Resistant Epithelial Ovarian Cancer With KRAS Wild-type (PaLiDo)

Epithelial Ovarian Cancer

Denmark, Belgium, Sweden, Austria
Idorsia Pharmaceuticals Ltd.

Completed

A Study to Investigate the Interaction Between ACT-246475 and Clopidogrel, Prasugrel, and Ticagrelor in Healthy Subjects

Healthy

United States
University of Sao Paulo

Completed

Platelet Aggregation and Adenosine Levels Among Patients Taking Ticagrelor or Prasugrel

Coronary Artery Disease

Brazil
Hull University Teaching Hospitals NHS Trust

Completed

Is Efficacy of PLAtelet Aggregation Inhibition by Ticagrelor Mediated P2Y12 Blockade Dependent Upon Endogenous Endothelial Nitric OXide? (PLATE NOX)

Acute Coronary Syndome

United Kingdom
The University of Hong Kong

Completed

Genotype Guided Versus Conventional Approach in Selection of Oral P2Y12 Receptor Blocker in Chinese Patients Suffering From Acute Coronary Syndrome

Acute Coronary Syndrome

Hong Kong
Centro Cardiologico Monzino
IRCCS National Neurological Institute "C. Mondino" Foundation

Recruiting

Antiplatelet Therapies in Patients With Depression and Coronary Disease (ENHANCE)

Depression | Coronary Artery Disease

Italy
Assistance Publique - Hôpitaux de Paris

Recruiting

Evaluation of Low Dose Colchicine and Ticagrelor in Prevention of Ischemic Stroke in Patients With Stroke Due to Atherosclerosis (RIISC-THETIS)

Myocardial Infarction | Stroke | Atherosclerosis | Cerebral Infarction | Stroke, Ischemic | Cardiac Disease | Coronary Syndrome | TIA

France
Arkansas Heart Hospital
University of Alabama at Birmingham; The University of Texas Health Science...

Terminated

Ticagrelor and Peripheral Arterial Disease

Peripheral Arterial Disease

United States
Yonsei University

Recruiting

Effect of High-intensity Statin With Ezetimibe COmbination theRapy Versus High-intensity sTatin Monotherapy After Percutaneous Coronary Intervention With Drug-eluting Stents; the ESCORT Trial

Coronary Artery Disease Requiring Coronary Revascularization With Newer Generation DES Implantation

Korea, Republic of
Peking Union Medical College Hospital

Recruiting

Belimumab Treatment for IgG4-related Disease

IgG4-related Disease

China
VA Office of Research and Development

Completed

Plaque Regression and Progenitor Cell Mobilization With Intensive Lipid Elimination Regimen (PREMIER), Phase II (PREMIER)

Acute Coronary Artery Syndrome

United States
VA Office of Research and Development

Completed

Plaque Regression and Progenitor Cell Mobilization With Intensive Lipid Elimination Regimen (PREMIER), Phase I (PREMIER)

Acute Coronary Syndrome

United States
University at Buffalo

Completed

Dapagliflozin As Additional Treatment To Liraglutide And Insulin In Patients With Type 1 Diabetes

Type 1 Diabetes Mellitus

United States
University of Wisconsin, Madison
Novartis Pharmaceuticals

Terminated

Mycophenolic Acid (MPA) Monotherapy in Liver Transplantation

Liver Transplant

United States
Galderma R&D

Completed

ORCA - Oracea® for Rosacea: A Community-based Assessment

Rosacea

United States
Sanofi

Terminated

Japanese Study With Rimonabant in Obese Type 2 Diabetic Patients With Oral Anti-diabetic Drug (SYMPHONY)

Obesity | Diabetes Mellitus Type 2

Japan
NYU Langone Health

Completed

Ticagrelor in Methotrexate-Resistant Rheumatoid Arthritis (TIMERA)

Rheumatoid Arthritis

United States
Juan Badimon

Completed

Platelet Sub-study of the TWILIGHT Trial

Myocardial Infarction | Coronary Artery Disease

United States
Hellenic Cardiovascular Research Society

Completed

A Multicenter Trial to Assess the MIcrovascular Integrity and Left Ventricular Function Recovery After Clopidogrel or TicagrelOr Administration, in Patients With STEMI Treated With Thrombolysis - The 'MIRTOS' Study (MIRTOS)

Myocardial Infarction | ST Segment Elevation Myocardial Infarction (STEMI)

Greece
Medical University of Vienna

Unknown

Add-on Cangrelor in STEMI-triggered Cardiac Arrest

Cardiopulmonary Arrest With Successful Resuscitation | ACS - Acute Coronary Syndrome | Hypothermia, Induced

Austria
Papworth Hospital NHS Foundation Trust
AstraZeneca

Unknown

TIMES: Ticagrelor vs. Placebo/ Clopidogrel With Aspirin in Anterior STEMI Patients Treated With Primary PCI

ST Elevation Myocardial Infarction

United Kingdom
Unity Health Toronto

Unknown

Optimizing Timing of CABG in Patients Presenting With ACS and Treated With Ticagrelor (CABG-TIME)

Coronary Artery Disease

Canada
University of Patras

Completed

Differential Effect of Ticagrelor Versus Prasugrel on the Adenosine-induced Coronary Vasodilatory Responses in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

Acute Coronary Syndrome

Greece
University of Alabama at Birmingham

Completed

Crushed Ticagrelor Versus Eptifibatide Bolus + Clopidogrel

Acute Coronary Syndrome | Angina, Unstable

United States
Massachusetts General Hospital
AstraZeneca

Withdrawn

Comparison of Ticagrelor Versus Clopidogrel on Residual Thrombus Burden During PCI: an OCT Study

Coronary Artery Disease | Acute Coronary Syndrome

United States
AstraZeneca

Completed

A Phase IV Study of the Onset and Maintenance of the Antiplatelet Effect of Ticagrelor Compared With Clopidogrel in Chinese Patients With ACS (HouYi)

Non-ST or ST Elevation Acute Coronary Syndromes

China
AstraZeneca

Completed

Study to Assess the Effect of Ticagrelor on Coronary Blood Flow in Healthy Male Subjects.

Blood Flow Speed | Coronary Flow Velocity

Sweden
Andalusian Initiative for Advanced Therapies -...

Unknown

Safety and Efficacy of Ticagrelor vs Clopidogrel in Patients With Acute Coronary Syndrome

Acute Coronary Syndromes

Spain
North Texas Veterans Healthcare System

Unknown

Study Comparing Treatment Effectiveness of Guideline Indicated APT for ACS in Patients With CKD (CPRS-CKD)

Chronic Kidney Diseases | Acute Coronary Syndrome

United States
LifeBridge Health
AstraZeneca

Unknown

Overcoming High On-Treatment Platelet Reactivity (HPR) During Prasugrel Therapy With Ticagrelor (HEIGHTEN)

Coronary Artery Disease

United States
AstraZeneca

Withdrawn

Adenosine-induced Myocardial Blood Flow in Peripheral Artery Disease Patients (PAD)

Intermittent Claudication | Peripheral Artery Disease | Vascular Disease | Arterial Occlusion Disease | Ankle Brachial Index (0.9 or Less)
AstraZeneca

Completed

Study to See if Platelet Transfusion Stop or Lessen the Effect of the Drug on Platelets

Inhibition on Platelet Aggregation

United States
Yonsei University

Recruiting

Tailored Anti-platelet Therapy After DES Implantation in High-risk Patients

Coronary Artery Disease

Korea, Republic of
Air Force Military Medical University, China

Withdrawn

Anticoagulation for Non-occlusive Portal Vein Thrombosis in Patients With Liver Cirrhosis

Liver Cirrhosis | Anticoagulation | Portal Vein Thrombosis
Andrea Harzstark
Novartis

Withdrawn

Everolimus/Sorafenib or Sunitinib in Patients With Metastatic Renal Cell Carcinoma (RCC)

Locally Metastatic Malignant Neoplasm
University of Florida
Janssen, LP

Completed

Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease (SWAP-AC)

Coronary Artery Disease

United States
East and North Hertfordshire NHS Trust
University of Hertfordshire

Unknown

Can Very Low Dose Rivaroxaban in Addition to Dual Antiplatelet Therapy (DAPT) Improve Thrombotic Status in Acute Coronray Syndrome (ACS) ACS (VaLiDate-R)

Acute Coronary Syndrome

United Kingdom
Moustafa Mohammed Abouelea

Recruiting

Role of Triptorelin 0.1 mg as a Luteal Phase Support in Assisted Reproductive Technique After Embryo Transfer : a Randomized Controlled Trial

Effect of Adding GnRHa as Luteal Phase Support in Antagonist ART Cycles

Egypt
MedImmune LLC

Completed

MEDI5083 Alone and in Combination With Durvalumab, Tremelimumab, and/or Docetaxel.

Advanced Solid Tumors

United States, Australia

3

Subscribe